Feedback / Questions
AVS100 - Avstera
https://www.prnewswire.com/news-releases/avstera-therapeutics-closes-seed-round-to-advance-its-lead-programs-targeting-solid-tumors-301673398.html
Nov 9, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev